MedPath
HSA Approval

ZOPICLONE TABLET 7.5 mg

SIN11416P

ZOPICLONE TABLET 7.5 mg

ZOPICLONE TABLET 7.5 mg

October 27, 2000

PHARMLINE MARKETING PTE. LTD.

PHARMLINE MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMLINE MARKETING PTE. LTD.
Licence HolderPHARMLINE MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05CF01

zopiclone

Manufacturer Information

PHARMLINE MARKETING PTE. LTD.

DRAGENOPHARM APOTHEKER PUSCHL GMBH & CO KG

Active Ingredients

ZOPICLONE

7.5 mg

Zopiclone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZOPICLONE TABLET 7.5 mg - HSA Approval | MedPath